The 5 analysts offering 12-month price forecasts for Solid Biosciences Inc have a median target of 3.00, with a high estimate of 5.00 and a low estimate of 2.00. The median estimate represents a +10.70% increase from the last price of 2.71.
The current consensus among 6 polled investment analysts is to Sell stock in Solid Biosciences Inc. This rating has held steady since July, when it was unchanged from a Sell rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.42
Reporting Date Aug 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.